Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Genotyping of human Mycobacterium kansasii isolates from Poland. Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
The prevalence of the Beijing genotype Mycobacterium tuberculosis strains in Istanbul Source: Eur Respir J 2005; 26: Suppl. 49, 191s Year: 2005
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019
In vitro activity of quinolones and macrolides against Mycobacterium avium complex:a comparison of isolate susceptibility in two general hospitals and one tuberculosis sanatorium located in the same area of JapanSource: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018
Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001
Mycobacterium tuberculosis (MTB) content in the air of in-patient facility for the management of pulmonary tuberculosis (TB)Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001
Mycobacterium tuberculosis resistance Source: Eur Respir J 2002; 20: Suppl. 38, 360s Year: 2002
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Analysis of mutations in multiple-drug-resistant M. tuberculosis strains isolated in Kyrgyzstan Source: Eur Respir J 2006; 28: Suppl. 50, 380s Year: 2006
Does Mycobacterium bovis appear among the clinical Mycobacterium tuberculosis complex isolates from TB patients of university hospital in Warsaw between 1999 and 2007? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008
Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS) Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001
DNA fingerprint analysis of Mycobacterium tuberculosis complex strains isolated from homeless tuberculosis patients in Budapest Source: Eur Respir J 2004; 24: Suppl. 48, 424s Year: 2004
Circulation of multidrug resistant strains of Mycobacterium tuberculosis in Abkhasia Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006
Mycobacterium tuberculosis drug resistance surveillance in BelarusSource: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005